ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ORMP Company Profile and Key Details

NASDAQ : ORMP

Oramed Pharmaceuticals Inc.

$2.23

-0.04-1.76%

At Close 4:00 PM

62.98

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

ORMP Stock Price Chart

Stock Price Today

Oramed Pharmaceuticals Inc. (ORMP) stock declined over -1.76%, trading at $2.23 on NASDAQ, down from the previous close of $2.27. The stock opened at $2.21, fluctuating between $2.21 and $2.29 in the recent session.

Stock Snapshot

2.27

Prev. Close

2.21

Open

91.1M

Market Cap

40.85M

Number of Shares

2.205

Day Low

2.29

Day High

-4.65

P/E Ratio

80.23%

Free Float in %

-0.48

EPS (TTM)

3.69

Book Value

-0.43

Cash Flow per Share

34.66K

Volume

Relevant Articles

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 15, 2025	2.21	2.29	2.21	2.23	34.69K
Apr 14, 2025	2.20	2.30	2.20	2.27	115.21K
Apr 11, 2025	2.10	2.15	2.09	2.11	94.34K
Apr 10, 2025	2.11	2.13	2.01	2.13	53.68K
Apr 09, 2025	2.02	2.21	1.82	2.12	258.53K
Apr 08, 2025	2.16	2.26	2.03	2.03	102.16K
Apr 07, 2025	2.05	2.12	2.04	2.10	62.91K
Apr 04, 2025	2.15	2.19	2.06	2.10	102.06K
Apr 03, 2025	2.12	2.37	2.12	2.17	154.57K
Apr 02, 2025	2.11	2.20	2.11	2.20	63.82K
Apr 01, 2025	2.16	2.16	2.06	2.13	91.21K
Mar 31, 2025	2.21	2.23	2.08	2.14	110.09K
Mar 28, 2025	2.32	2.32	2.18	2.21	74.08K
Mar 27, 2025	2.38	2.40	2.30	2.30	39.04K
Mar 26, 2025	2.31	2.38	2.30	2.36	48.5K
Mar 25, 2025	2.34	2.39	2.31	2.33	30.9K
Mar 24, 2025	2.33	2.36	2.31	2.34	18.38K
Mar 21, 2025	2.39	2.39	2.31	2.33	16.9K
Mar 20, 2025	2.35	2.41	2.34	2.37	22.88K
Mar 19, 2025	2.42	2.42	2.32	2.35	26.4K

Contact Details

New York, NY 10036

United States

Website: https://www.oramed.comContact: 844 967 2633

About Company

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Frequently Asked Questions

What is the current Oramed Pharmaceuticals Inc. (ORMP) stock price?

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) stock price is $2.23 in the last trading session. During the trading session, ORMP stock reached the peak price of $2.29 while $2.21 was the lowest point it dropped to. The percentage change in ORMP stock occurred in the recent session was -1.76% while the dollar amount for the price change in ORMP stock was -$0.04.

ORMP's industry and sector of operation?

The NASDAQ listed ORMP is part of Biotechnology industry that operates in the broader Healthcare sector. Oramed Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ORMP?

Dr. Miriam Kidron Ph.D.
Chief Scientific Officer & Director
Mr. Netanel Derovan
Chief Legal Officer & Company Sec.
Mr. Michael Rabinowitz
Chief Commercial Officer
Dr. Roy Eldor M.D., Ph.D.
Chief Medical Advisor & Member of the Scientific Advisory Board
Mr. David Silberman CPA
Chief Financial Officer & Treasurer
Mr. David Silberman C.P.A.
Chief Financial Officer & Treasurer
Mr. Nadav Kidron Esq.
Pres, Chief Executive Officer & Executive Chairman
Mr. Joshua Hexter
Chief Operating & Bus. Officer

How ORMP did perform over past 52-week?

ORMP's closing price is 22.53% higher than its 52-week low of $1.82 where as its distance from 52-week high of $3.09 is -27.83%.

How many employees does ORMP have?

Number of ORMP employees currently stands at 13.

Link for ORMP official website?

Official Website of ORMP is: https://www.oramed.com

How do I contact ORMP?

ORMP could be contacted at phone 844 967 2633 and can also be accessed through its website. ORMP operates from 1185 Avenue of the Americas, New York, NY 10036, United States.

How many shares of ORMP are traded daily?

ORMP stock volume for the day was 34.66K shares. The average number of ORMP shares traded daily for last 3 months was 252.04K.

What is the market cap of ORMP currently?

The market value of ORMP currently stands at $91.10M with its latest stock price at $2.23 and 40.85M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	13
Beta	1.49
Sales or Revenue	$2.70M
5Y Sales Change%	-0.785%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology